Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biospecifics Technologies Corp (NASDAQ:BSTC)

During the Trading Day
48.28 +1.03 / +2.18%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
48.17 -0.11 / -0.23%
Volume: 509.00
Health Technology
Pharmaceuticals: Other

Company Description

BioSpecifics Technologies Corp. is a biopharmaceutical company, which engages in development of an injectable collagenase for multiple indications. Its product XIAFLEX is an injectable collagenase enzyme, which is used for the treatment of Dupuytren's contracture in adults with a palpable cord in the palm. The company was founded in 1990 and is headquartered in Lynbrook, NY.

Contact Information

Biospecifics Technologies Corp.
35 Wilbur Street
Lynbrook New York 11563
P:(516) 593-7000
Investor Relations:



Individual stakeholders38.12%
Other institutional34.30%
Mutual fund holders19.85%

Top Executives

Thomas L. WegmanPresident, CEO, CFO, Director & CAO
James GorisController